As more transmissible COVID-19 variants continue to emerge and experts warn of the potential for waning effectiveness of vaccines against severe disease, health officials are advising...
On Nov. 19, Health Canada announced the approval of the Pfizer-BioNTech two-dose COVID-19 vaccine for children between five and 11-years-old, allowing children in that age group...
The National Advisory Committee on Immunization (NACI) is now recommending that people who received a first dose of the Oxford-AstraZeneca vaccine receive a second dose of...